Nuestra página de facturación está certificada por:
Long-term use of osteoporosis medication may reduce bone fracture risk for ... - Science Codex
Science CodexLong-term use of osteoporosis medication may reduce bone fracture risk for .
Long-term use of osteoporosis medication may reduce bone fracture risk for ... - Medical Xpress
Long-term use of osteoporosis medication may reduce bone fracture risk for .
Thigh fractures linked to osteoporosis drugs; long-term use questioned - Harvard Health Publications (blog)
MyFox PhiladelphiaThigh fractures linked to osteoporosis drugs; long-term use questionedHarvard Health Publications (blog)Since bisphosphonates such as alendronate (Fosamax), ibandronate (Boniva), risedronate (Actonel), and zoledronic acid (Reclast) were first introduced in the mid-1990s, they've become a staple of osteoporosis treatment.
National Fosamax Side Effect Lawyers Report on Study Confirming Increased Risk ... - DigitalJournal.com (press release)
National Fosamax Side Effect Lawyers Report on Study Confirming Increased Risk .
Bisphosphonates 'can be stopped after three years' - Pulse
Bisphosphonates 'can be stopped after three years'PulseShe said: 'Review patients after three to five years on therapy and discontinue alendronate or zoledronate in those without previous vertebral fractures with osteopenic bone mineral density.